T1	Treatment 94 106	topiroxostat
T2	Treatment 244 287	new xanthine oxidase inhibitor topiroxostat
T3	Treatment 397 422	oral dose of topiroxostat
T4	Treatment 430 475	180 mg), moxifloxacin (400 mg) or placebo
T5	Treatment 662 687	prolonged by moxifloxacin
T6	Treatment 1245 1264	in the sex subgroup
